IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lanxess Posts Huge Hike in Profits; Raises Earnings Forecast; Scales Back Cost-Cutting Plans

3:47 AM MDT | August 6, 2010 | Natasha Alperowicz

Lanxess beat market expectations for the second quarter as a result of a strong performance in emerging markets, reporting Ebitda pre-exceptionals of €269 million ($354 million) compared to €112 million in the year-earlier period. Sales were up 48% at €1.83 billion and net profit soared to €131 million from €17 million in the second quarter of 2009. The company has raised its earnings forecast for 2010 and now expects Ebitda pre-exceptionals of "roughly €800 million," compared with forecasts made in May of €650 million...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa